• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝炎:概述

Non-alcoholic steatohepatitis: an overview.

作者信息

Shifflet Allison, Wu George Y

机构信息

Division of Gastroenterology-Hepatology, Department of Medicine, University of Connecticut Health Center, Farmington, Connecticut, USA.

出版信息

J Formos Med Assoc. 2009 Jan;108(1):4-12. doi: 10.1016/S0929-6646(09)60026-7.

DOI:10.1016/S0929-6646(09)60026-7
PMID:19181602
Abstract

Non-alcoholic fatty liver disease (NAFLD) includes a broad spectrum of fat-induced liver injury, ranging from mild steatosis to cirrhosis and liver failure. The presence of obesity and insulin resistance is strongly associated with non-alcoholic fatty liver and a greater risk of advanced disease. We present here a review of the mechanisms involved in the pathogenesis of NAFLD, advances in the diagnosis, and options for treatment.

摘要

非酒精性脂肪性肝病(NAFLD)包括一系列由脂肪引起的肝损伤,范围从轻度脂肪变性到肝硬化和肝衰竭。肥胖和胰岛素抵抗的存在与非酒精性脂肪肝密切相关,且发生晚期疾病的风险更高。我们在此对NAFLD发病机制、诊断进展及治疗选择方面的相关内容进行综述。

相似文献

1
Non-alcoholic steatohepatitis: an overview.非酒精性脂肪性肝炎:概述
J Formos Med Assoc. 2009 Jan;108(1):4-12. doi: 10.1016/S0929-6646(09)60026-7.
2
Non-alcoholic fatty liver disease: further expression of the metabolic syndrome.非酒精性脂肪性肝病:代谢综合征的进一步表现。
J Gastroenterol Hepatol. 2007 Mar;22(3):293-303. doi: 10.1111/j.1440-1746.2007.04824.x.
3
Non-alcoholic steatohepatitis in children.儿童非酒精性脂肪性肝炎
Pediatr Transplant. 2004 Dec;8(6):613-8. doi: 10.1111/j.1399-3046.2004.00241.x.
4
Non-alcoholic fatty liver disease: the hepatic consequence of obesity and the metabolic syndrome.非酒精性脂肪性肝病:肥胖和代谢综合征的肝脏后果。
Proc Nutr Soc. 2010 May;69(2):211-20. doi: 10.1017/S0029665110000030. Epub 2010 Feb 17.
5
The epidemiology, pathogenesis and histopathology of fatty liver disease.脂肪性肝病的流行病学、发病机制和组织病理学。
Histopathology. 2012 Aug;61(2):141-52. doi: 10.1111/j.1365-2559.2011.04145.x. Epub 2012 Feb 28.
6
Non-alcoholic fatty liver disease.非酒精性脂肪性肝病。
J Diabetes. 2012 Sep;4(3):266-80. doi: 10.1111/j.1753-0407.2012.00204.x.
7
Review article: non-alcoholic fatty liver disease and hepatitis C--risk factors and clinical implications.综述文章:非酒精性脂肪性肝病与丙型肝炎——危险因素及临床意义
Aliment Pharmacol Ther. 2005 Nov;22 Suppl 2:48-51. doi: 10.1111/j.1365-2036.2005.02596.x.
8
[Obesity and non-alcoholic steatohepatitis].
Gac Med Mex. 2004 Jul-Aug;140 Suppl 2:S67-72.
9
Nonalcoholic fatty liver disease.非酒精性脂肪性肝病
Rev Gastroenterol Disord. 2002;2(1):11-9.
10
Pathogenesis of non-alcoholic steatohepatitis: human data.非酒精性脂肪性肝炎的发病机制:人类数据。
Clin Liver Dis. 2007 Feb;11(1):75-104, ix. doi: 10.1016/j.cld.2007.02.011.

引用本文的文献

1
Implication of Hypotension in the Pathogenesis of Cognitive Impairment and Brain Injury in Chronic Liver Disease.低血压在慢性肝脏疾病认知障碍和脑损伤发病机制中的意义。
Neurochem Res. 2024 Jun;49(6):1437-1449. doi: 10.1007/s11064-022-03854-z. Epub 2023 Jan 13.
2
Just Drink a Glass of Water? Effects of Bicarbonate-Sulfate-Calcium-Magnesium Water on the Gut-Liver Axis.只喝一杯水?碳酸氢盐-硫酸盐-钙-镁水对肠-肝轴的影响。
Front Pharmacol. 2022 Jun 28;13:869446. doi: 10.3389/fphar.2022.869446. eCollection 2022.
3
Obesity and metabolic outcomes in a safety-net health system.
安全网医疗系统中的肥胖与代谢结果
Biodemography Soc Biol. 2020 Jul-Sep;65(3):257-267. doi: 10.1080/19485565.2020.1765732.
4
Role of MicroRNAs in Pathophysiology of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis.微小RNA在非酒精性脂肪性肝病和非酒精性脂肪性肝炎病理生理学中的作用
Middle East J Dig Dis. 2018 Oct;10(4):213-219. doi: 10.15171/mejdd.2018.113. Epub 2018 Jul 17.
5
Gemfibrozil reduces lipid accumulation in SMMC-7721 cells via the involvement of PPARα and SREBP1.吉非贝齐通过过氧化物酶体增殖物激活受体α(PPARα)和固醇调节元件结合蛋白1(SREBP1)减少SMMC - 7721细胞中的脂质积累。
Exp Ther Med. 2019 Feb;17(2):1282-1289. doi: 10.3892/etm.2018.7046. Epub 2018 Dec 5.
6
Improvement of non-alcoholic steatohepatitis by hepatocyte-like cells generated from iPSCs with Oct4/Sox2/Klf4/Parp1.由携带Oct4/Sox2/Klf4/Parp1的诱导多能干细胞生成的肝样细胞对非酒精性脂肪性肝炎的改善作用
Oncotarget. 2018 Jan 2;9(26):18594-18606. doi: 10.18632/oncotarget.23603. eCollection 2018 Apr 6.
7
Steatosis and hepatitis C.脂肪变性和丙型肝炎。
Gastroenterol Rep (Oxf). 2016 Feb;4(1):24-9. doi: 10.1093/gastro/gov040. Epub 2015 Aug 13.
8
Association between metabolic syndrome and the development of non-alcoholic fatty liver disease.代谢综合征与非酒精性脂肪性肝病发生之间的关联
Exp Ther Med. 2013 Jul;6(1):77-84. doi: 10.3892/etm.2013.1090. Epub 2013 Apr 29.
9
Severe diabetes and leptin resistance cause differential hepatic and renal transporter expression in mice.严重糖尿病和瘦素抵抗导致小鼠肝脏和肾脏转运蛋白表达存在差异。
Comp Hepatol. 2012 Apr 23;11(1):1. doi: 10.1186/1476-5926-11-1.
10
Treatment options for nonalcoholic fatty liver disease.非酒精性脂肪性肝病的治疗选择。
Therap Adv Gastroenterol. 2010 Mar;3(2):121-37. doi: 10.1177/1756283X09359964.